Citius Pharmaceuticals P/E Ratio 2011-2026 | CTXR

Annual P/E Ratio Citius Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
-0.214	-0.614	-0.143	-4.86	-4.71	-2.19	-0.713	-1.26	-1.69	-4.19	-13.9	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.143	-13.9	-3.14

P/E Ratio of other stocks in the Biotechnology industry

Issuer	P/E Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-2.15	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	-0.612	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	-0.183	-	1.35 %	$ 17.8 M	China
Coherus BioSciences CHRS	1.35	$ 1.64	1.86 %	$ 192 M	USA
AgeX Therapeutics AGE	5.53	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-0.236	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	55.7	-	-	$ 40.3 B	USA
Biophytis SA BPTS	-17.6	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	2.49 K	-	2.54 %	$ 160 B	France
BioNTech SE BNTX	-19.4	$ 92.25	0.12 %	$ 22.3 B	Germany
AstraZeneca PLC AZN	16.3	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.57	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-0.0167	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-18.5	-	0.74 %	$ 768 M	Israel
Compugen Ltd. CGEN	5.55	$ 2.65	-5.36 %	$ 248 M	Israel
Abcam plc ABCM	-581	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-0.403	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-251	-	-18.52 %	$ 27.3 M	Britain
Enlivex Therapeutics Ltd. ENLV	0.0355	$ 0.68	-4.67 %	$ 31.1 M	Israel
Esperion Therapeutics ESPR	-24.7	$ 3.12	-0.32 %	$ 649 M	USA
Eton Pharmaceuticals ETON	-121	$ 31.29	-3.99 %	$ 842 M	USA
Affimed N.V. AFMD	-9.16	-	-34.95 %	$ 21.5 M	Germany
Forte Biosciences FBRX	-4.83	$ 21.94	1.62 %	$ 284 M	USA
Институт стволовых клеток человека ISKJ	38.8	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-0.859	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-0.259	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-1.19	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	-1.41	-	-	$ 344 M	USA
IMV IMV	-0.18	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-12.9	-	-	$ 3.67 B	USA
Akouos AKUS	-2.12	-	0.23 %	$ 488 M	USA
Grifols, S.A. GRFS	21.2	$ 8.01	-	$ 5.44 B	Spain
Ayala Pharmaceuticals AYLA	-0.203	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	-9.92	$ 0.88	2.85 %	$ 147 M	USA
Cyclacel Pharmaceuticals CYCCP	0.00975	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	-2.93	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-4.4	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	-19.7	$ 14.89	0.07 %	$ 214 M	USA
Advaxis ADXS	-0.0388	-	-9.65 %	$ 45.9 M	USA
InflaRx N.V. IFRX	-1.39	$ 2.74	4.98 %	$ 184 M	Germany
Aeterna Zentaris AEZS	-0.964	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-3.48	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-8.58	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	-0.735	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-1.33	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-0.489	$ 3.44	1.18 %	$ 5.66 M	Israel
Aptose Biosciences APTO	-0.0913	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-0.146	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-16.1	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-0.189	-	4.14 %	$ 49.1 M	USA